Medical/Pharmaceuticals
Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories
MONTREAL, Jan. 12, 2021 /PRNewswire/ -- Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners ("Arsenal"), announced today the acquisition of Mosaic Laboratories LLC ("Mosaic"), aCalifornia-based company offering histology and immu...
2021-01-12 21:20
3111
Beactica Therapeutics and University of Dundee announce collaboration to develop WRN inhibitors to target cancer
STOCKHOLM, Jan. 12, 2021 /PRNewswire/ -- Beactica Therapeutics AB, the Swedish drug discovery company, andUniversity of Dundee, a top-ranked university in the UK for biological sciences, today announced a new research collaboration agreement. The two parties will work together in a project aimed ...
2021-01-12 17:26
1245
IKEUCHI Launches New Fogging Device for Quick, Easy and Effective Disinfection
OSAKA, Japan, Jan. 12, 2021 /PRNewswire/ -- H. IKEUCHI & CO., LTD., a leading manufacturer of industrial and commercial spray nozzles, headquartered inJapan, has launched full-scale sales of a backpack disinfection device dubbed "Dry-Fog HIGHNOW (R)." Logo: https://kyodonewsprwire.jp/prwfile/re...
2021-01-12 16:00
1402
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, Jan. 12, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
2021-01-12 13:02
6888
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference BOSTON, Jan. 11, 2021 /PRNewswire/ -- Valo Health LLC (Valo), the technology company working to transform the drug discovery and development process and accelerate the creation of life-changin...
2021-01-12 12:26
1983
Gannex Announces Positive Phase I Clinical Results on Its THR-β Agonist ASC41
SHANGHAI, Jan. 11, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces the positive phase I clinical results of ASC41 oral ...
2021-01-12 08:30
2869
MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio
MedSkin Solutions Dr. Suwelack AG announces receiving FDA 510(k) clearance for its flagship Med Care product portfolio MatriDerm®. HAMBURG, Germany, Jan. 12, 2021 /PRNewswire/ -- MatriDerm® is a single-use three-dimensional acellular dermal matrix composed of bovine collagen fibers and bovine el...
2021-01-12 04:38
1598
ClearMind Biomedical's Axonpen Neuroendoscope Receives 510K Clearance
LOS ANGELES, Jan. 11, 2021 /PRNewswire/ -- ClearMind Biomedical has received
FDA clearance for its novel neuroendoscope, the Axonpen System, for
illumination and visualization of intracranial tissue and fluids, and the
controlled aspiration of tissue and/or fluid during surgery.
2021-01-12 01:00
1346
Regent Pacific Announces Key Research Findings On FORTACIN™
HONG KONG, Jan. 11, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce several key findings on the w...
2021-01-11 23:36
10033
Korea Fair Trade Commission Assigns Compliance Program Rating of "A" to Yuyu Pharma
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) received Compliance Program (CP) Rating of "A" from the Korea Fair Trade Commission (FTC). Yuyu Pharma (Yuyu) established its CP team in 2016 with the help of the law firm Kim & Chang. The CP tea...
2021-01-11 22:00
4801
PharmAbcine announces a research collaboration with LegoChem Biosciences
DAEJEON, South Korea, Jan. 11, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company has entered into a research collaboration agreement with LegoChem Bioscience...
2021-01-11 21:00
1608
Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services
Formerly Parexel Informatics, Calyx is a market-leading Medical Imaging, eClinical, and Regulatory solutions provider NOTTINGHAM, England, Jan. 11, 2021 /PRNewswire/ -- Calyx, a leading provider of Medical Imaging, eClinical, and Regulatory solutions and services to solve complex challenges in c...
2021-01-11 19:05
2195
Airnov Made Its Debut at CPhI China
SHANGHAI, Jan. 11 2021 /PRNewswire/ -- Airnov Healthcare Packaging made its debut successfully at the CPhI China 2020 at Shanghai New International Expo Center on December 16-18. The global leader in healthcare packaging attended the event with its latest innovations including HAT® IN desiccant v...
2021-01-11 16:26
2632
Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA.
SHENZHEN, China, Jan. 11, 2021 /PRNewswire/ -- On January 8, 2021, Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) submitted its pivotal phase III clinical trial application (IND) of national class I innovative drug Chiauranib to NMPA, for the treatment...
2021-01-11 11:33
3041
Antengene to Present at the 39th Annual J.P. Morgan Healthcare Conference
SHANGHAI and SAN FRANCISCO, Jan. 11, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology an...
2021-01-11 07:26
2099
Standigm and SK Chemicals Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Standigm Inc.("Standigm"), an AI-based drug discovery company and SK Chemicals Co., Ltd.("SK Chemicals"), a life science and green chemicals company, announced that they had successfully found a new arthritis indication for an FDA-approved drug an...
2021-01-11 07:00
1947
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients
SUZHOU, China, Jan. 10, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients. The investigator initiated trial conducted by Dr.Andy Goren and Dr. Flávio Adsuara C...
2021-01-10 16:55
3796
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
SHANGHAI, Jan. 9, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients inGreater China, announced today the closing of a$150 million Series B financing. The round...
2021-01-09 11:06
5911
Appian Selected by Accenture as a Core Partner in the INTIENT Network for Life Sciences
Appian brings low-code speed and automation power to help drive innovation in drug discovery and scientific research MCLEAN, Va., Jan. 9, 2021 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced that it has joined Accenture's INTIENT partner ecosystem as a core partner. The ecosystem is design...
2021-01-09 08:55
10491
NTC grants to Zhaoke exclusive license and distribution rights in Asia for NTC014, innovative drug for bacterial conjunctivitis
MILAN and HONG KONG, Jan. 8, 2021 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical company headquartered inItaly, and Zhaoke (Hong Kong) Ophthalmology Pharmaceuticals Limited, having a fully integrated ophthalmic platform with strong foundation in eyecare, announce today their agr...
2021-01-08 20:55
6071
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07
BeLive Studios, NewUnivers and ChopChop Systems Sign Memorandum of Understanding at ATF 2025
[Picked up by 288 media titles]
2025-12-08 11:00
Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 286 media titles]
2025-12-10 16:00
Most Read
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
2025-12-06 09:00
4965
MALAYSIA REMAINS COMMITTED TO ACCELERATE TRANSFORMATIVE SOLUTIONS FOR A SUSTAINABLE AND INCLUSIVE FUTURE
2025-12-06 00:41
4050
Taipei City's Global Pass: A New Partner Channel for Global Startup Spaces
2025-12-06 01:06
3932
Dreame Technology Recognized on Fast Company's List of Brands That Matter
2025-12-06 01:30
3444
Cyient Semiconductors Qualifies for Key Bid in Semi-Conductor Laboratory-Mohali Revamp
2025-12-06 02:00
2687